Naturally occurring selenium compounds in cancer chemoprevention trials: A workshop summary

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 1, 1997, Pages 63-69

  Patterson, Blossom H ^a   Levander, Orville A ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM DERIVATIVE;

ARTICLE; CANCER PREVENTION; CANCER RESEARCH; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG RESEARCH; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CLINICAL TRIALS; HUMANS; MAXIMUM ALLOWABLE CONCENTRATION; MICE; NEOPLASMS; NUTRITIONAL REQUIREMENTS; SELENIUM; TIME FACTORS;

EID: 0031015480     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Paterson, B. H., Levander, O. A., Helzlsouer, K., McAdam, P. A., Lewis, S. A., Taylor, P. R., Veillon, C., and Zech, L. A. Human selenite metabolism: a kinetic model. Am. J. Physiol., 257: 556-567, 1989.
2. 74Se] selenomethionine metabolism: a kinetic model. Am. J. Clin. Nutr., 54: 917-926, 1991.
3. Burk, R. F. Selenium and cancer: meaning of serum selenium levels. J. Nutr., 116: 1584-1584, 1986.